Kayyem Jon Faiz — SEC insider filings

SEC reporting owner CIK 1366268. 38 insider filings on record with FilingPulse; latest filed 2026-09-23.

Transaction summary — filings shown

Covers all 38 filings on record, filed 2021-06-08 to 2026-09-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Inhibrx Biosciences, Inc. (INBX)Director1414 legs · 466,521 sh · $9,015,804—15
Inhibrx, Inc. (INBX)Director11—7 legs · 38,000 sh · $1,066,88315
BIODESIX INC (BDSX)Director131 leg · 173,913 sh · $200,000—19

Insider filings — Kayyem Jon Faiz

FiledFormIssuerReported transactionsSource
2026-09-234Inhibrx Biosciences, Inc. (INBX)Purchase (P): 5,000 @ $100EDGAR
2026-09-184/AInhibrx Biosciences, Inc. (INBX)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2026-09-174Inhibrx Biosciences, Inc. (INBX)Purchase (P): 5,000 @ $100EDGAR
2026-09-084Inhibrx Biosciences, Inc. (INBX)Purchase (P): 5,000 @ $113.52EDGAR
2026-06-044Inhibrx Biosciences, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-01-064BIODESIX INC (BDSX)Grant/award (A): 5,443 (derivative) @ $0 · Grant/award (A): 6,354 (derivative) @ $0EDGAR
2025-05-294Inhibrx Biosciences, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-05-224BIODESIX INC (BDSX)Grant/award (A): 68,621 (derivative) @ $0 · Grant/award (A): 42,010 (derivative) @ $0EDGAR
2025-03-284Inhibrx Biosciences, Inc. (INBX)Gift (G): 90,000 @ $0EDGAR
2024-12-174Inhibrx Biosciences, Inc. (INBX)Gift (G): 500,000 @ $0 · Gift (G): 250,000 @ $0 · Gift (G): 250,000 @ $0EDGAR
2024-12-064Inhibrx Biosciences, Inc. (INBX)Gift (G): 52,000 @ $0EDGAR
2024-11-224Inhibrx Biosciences, Inc. (INBX)Purchase (P): 34,843 @ $14.23 · Purchase (P): 34,843 @ $14.23 · Purchase (P): 18,750 @ $14.19 · Purchase (P): 18,750 @ $14.19EDGAR
2024-06-244Inhibrx Biosciences, Inc. (INBX)Gift (G): 89,050 @ $0 · Gift (G): 10,000 @ $0 · Gift (G): 10,000 @ $0EDGAR
2024-06-074Inhibrx Biosciences, Inc. (INBX)Purchase (P): 49,284 @ $17.23 · Purchase (P): 8,265 @ $17.89EDGAR
2024-06-044Inhibrx Biosciences, Inc. (INBX)Purchase (P): 70,193 @ $16.14 · Purchase (P): 46,792 @ $16.61 · Purchase (P): 80,738 @ $17.90 · Purchase (P): 65,337 @ $17.44 · Purchase (P): 23,726 @ $18.24EDGAR
2024-05-304Inhibrx Biosciences, Inc. (INXB)Grant/award (A): 806,075 · Grant/award (A): 6,250 · Grant/award (A): 6,250 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-05-304Inhibrx, Inc. (INBX)Disposition to issuer (D): 3,224,301 @ $30 · Disposition to issuer (D): 25,000 @ $30 · Disposition to issuer (D): 25,000 @ $30 · Disposition to issuer (D): 17,259 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +1 moreEDGAR
2024-05-234BIODESIX INC (BDSX)Grant/award (A): 46,686 (derivative) @ $0 · Grant/award (A): 37,050 (derivative) @ $0EDGAR
2024-01-034BIODESIX INC (BDSX)Grant/award (A): 105,389 (derivative) @ $0EDGAR
2023-08-074BIODESIX INC (BDSX)Grant/award (A): 6,172 @ $1.62EDGAR
2023-05-304Inhibrx, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-05-254BIODESIX INC (BDSX)Grant/award (A): 28,873 (derivative) @ $0EDGAR
2023-04-044BIODESIX INC (BDSX)Option exercise (M): 145,833 · Option exercise (M): 145,833 (derivative) @ $0EDGAR
2023-01-234Inhibrx, Inc. (INBX)Sale (S): 9,500 @ $25.26EDGAR
2023-01-054BIODESIX INC (BDSX)Grant/award (A): 4,878 (derivative) @ $0EDGAR
2023-01-044BIODESIX INC (BDSX)Grant/award (A): 62,500 (derivative) @ $0EDGAR
2022-12-224BIODESIX INC (BDSX)Option exercise (M): 31,619 · Option exercise (M): 31,619 (derivative) @ $0EDGAR
2022-12-224Inhibrx, Inc. (INBX)Sale (S): 7,541 @ $26.87 · Sale (S): 1,959 @ $27.61EDGAR
2022-11-224Inhibrx, Inc. (INBX)Sale (S): 2,733 @ $29.33 · Sale (S): 6,767 @ $30.12EDGAR
2022-11-214BIODESIX INC (BDSX)Purchase (P): 173,913 @ $1.15EDGAR
2022-10-244Inhibrx, Inc. (INBX)Sale (S): 3,572 @ $29.39 · Sale (S): 5,928 @ $30.58EDGAR
2022-08-254Inhibrx, Inc. (INBX)Gift (G): 11,900 @ $0EDGAR
2022-08-084Inhibrx, Inc. (INBX)Gift (G): 3,400 @ $0EDGAR
2022-08-024Inhibrx, Inc. (INBX)Gift (G): 118,500 @ $0 · Gift (G): 25,000 @ $0 · Gift (G): 25,000 @ $0EDGAR
2022-05-264BIODESIX INC (BDSX)Grant/award (A): 83,333 (derivative) @ $0EDGAR
2022-05-264Inhibrx, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-12-084BIODESIX INC (BDSX)Grant/award (A): 31,619 (derivative) @ $0 · Grant/award (A): 50,368 (derivative) @ $0 · Grant/award (A): 27,038 (derivative) @ $0EDGAR
2021-06-084Inhibrx, Inc. (INBX)Grant/award (A): 15,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-06-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1366268 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs